BR112023002377A2 - Processos de cultura de célula - Google Patents

Processos de cultura de célula

Info

Publication number
BR112023002377A2
BR112023002377A2 BR112023002377A BR112023002377A BR112023002377A2 BR 112023002377 A2 BR112023002377 A2 BR 112023002377A2 BR 112023002377 A BR112023002377 A BR 112023002377A BR 112023002377 A BR112023002377 A BR 112023002377A BR 112023002377 A2 BR112023002377 A2 BR 112023002377A2
Authority
BR
Brazil
Prior art keywords
cell culture
culture processes
processes
proteins
antibodies
Prior art date
Application number
BR112023002377A
Other languages
English (en)
Inventor
Ben Yahia Bassem
Philippe Thomas Piednoir Antoine
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of BR112023002377A2 publication Critical patent/BR112023002377A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCESSOS DE CULTURA DE CÉLULA. A presente invenção pertence ao campo da fabricação de proteínas recombinantes, particularmente proteínas, tais como anticorpos.
BR112023002377A 2020-08-20 2021-08-19 Processos de cultura de célula BR112023002377A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2012991.2A GB202012991D0 (en) 2020-08-20 2020-08-20 Cell culture processes
PCT/EP2021/073094 WO2022038250A1 (en) 2020-08-20 2021-08-19 Cell culture processes

Publications (1)

Publication Number Publication Date
BR112023002377A2 true BR112023002377A2 (pt) 2023-03-21

Family

ID=72660828

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023002377A BR112023002377A2 (pt) 2020-08-20 2021-08-19 Processos de cultura de célula

Country Status (13)

Country Link
US (1) US20230348850A1 (pt)
EP (1) EP4200432A1 (pt)
JP (1) JP2023538581A (pt)
KR (1) KR20230051277A (pt)
CN (1) CN115916814A (pt)
AR (1) AR123289A1 (pt)
AU (1) AU2021329034A1 (pt)
BR (1) BR112023002377A2 (pt)
CA (1) CA3190220A1 (pt)
GB (1) GB202012991D0 (pt)
IL (1) IL300509A (pt)
MX (1) MX2023002054A (pt)
WO (1) WO2022038250A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
WO2008013809A1 (en) 2006-07-24 2008-01-31 Amgen Inc. Cell culture methods
CA2687082C (en) 2007-05-11 2014-01-14 Amgen Inc. Improved feed media
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
EP3330370B1 (en) 2010-04-26 2021-02-24 Novartis AG Process for cultivation of cho cells
WO2013158275A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201411320D0 (en) 2014-06-25 2014-08-06 Ucb Biopharma Sprl Antibody construct

Also Published As

Publication number Publication date
CA3190220A1 (en) 2022-02-24
EP4200432A1 (en) 2023-06-28
JP2023538581A (ja) 2023-09-08
US20230348850A1 (en) 2023-11-02
WO2022038250A1 (en) 2022-02-24
KR20230051277A (ko) 2023-04-17
AU2021329034A1 (en) 2023-03-09
AR123289A1 (es) 2022-11-16
MX2023002054A (es) 2023-03-16
CN115916814A (zh) 2023-04-04
GB202012991D0 (en) 2020-10-07
IL300509A (en) 2023-04-01

Similar Documents

Publication Publication Date Title
CL2018002852A1 (es) Producción celular de ácido ribonucleico
CL2019002135A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas.
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
PH12014502868A1 (en) Cells for producing recombinant iduronate-2-sulfatase
BR112013005872A2 (pt) compostos, composição farmacêutica e respectivos usos
MX368142B (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
BR112022001207A2 (pt) Método de obtenção de mitocôndrias de células e mitocôndrias obtidas
AR083354A1 (es) Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto
EA201390639A1 (ru) Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих
BR112017008672A2 (pt) anticorpos de il-6 melhorados
BR112021021777A2 (pt) Métodos para a produção de ergotioneína
EA202091349A1 (ru) Способы культивирования клеток
BR112021025158A2 (pt) Composições de proteína anti-vegf e métodos para a produção das mesmas
TR201914501A2 (tr) Aeroponi̇k i̇ç ortam bi̇tki̇ yeti̇şti̇rme modülleri̇
BR112021024848A2 (pt) Métodos de purificação de anticorpos e composições dos mesmos
MX2022000253A (es) Proceso de fermentacion industrial para celulas microbianas mediante el uso de un precultivo de alimentacion por lotes.
CL2023000894A1 (es) Compuestos de heteroarilo fusionados y su uso como inhibidores de camkii
MX2023002221A (es) Sistema de baculovirus modificado para produccion mejorada de adn de extremo cerrado (adnce).
MX2016002870A (es) Moleculas que contienen fc que presentan perfiles de glicoforma predecibles, consistentes y reproducibles.
BR112021014220A2 (pt) Derivados heterocíclicos
BR112023002377A2 (pt) Processos de cultura de célula
PL439808A1 (pl) Sposoby i kompozycje hodowli komórkowych do produkcji przeciwciał
EA200900984A1 (ru) Улучшение клеточного роста
CO2017006157A2 (es) Método de manufactura de proteína
BR112015005797A2 (pt) processo para a produção de gelatina